Deep knowledge on small-molecule drugs

Instant access to actionable insights on pharmaceutical drugs

pharmaceutical portfolio management

Portfolio Management

PBM / Formulary and pharmacy & therapeutics (P&T)

Anticipate future budget requirements and proactively identify generic sources

Specialty pharmaceuticals and generics

Identify market entry opportunities and inform portfolio management decisions

identify generic sources

Business Intelligence

Branded pharmaceutical manufacturers

Assess past successes of patent challengers and elucidate research paths of competitors

Buyers, wholesalers, and distributors

Predict branded drug patent expiration, identify generic suppliers, and prevent overstock of branded drugs

API manufacturers

Obtain formulation and manufacturing information; identify final formulators, repackagers, and relabellers

Email Alerts

Set up watchlists for daily email updates

international drug patents and SPCs

Comprehensive Global Coverage

Drug patents in dozens of countries

European Supplementary Protection Certificates

Take your data with you

Export search results to Excel or CSV

Global Patent Coverage

Patent coverage in 130+ countries
Supplementary Protection Certificates

Intuitive Interface

Quickly filter and sort results

Email Alerts

See the full list features on the plans and pricing page

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Fortune- Generics' new legal attack: Big Pharma's aging patents CNN Money - Generics' new legal attack: Big Pharma's aging patents New England Journal of Medicine Barrons

Globalization of Pharmaceutical Drug Innovation The structure and business of biopharmaceutical companies including the management of risks and resources Drug Topics Nature Biotechnology Cardinal Health

Business Insider American Health & Drug Benefits National Bureau of Economic Research Analytical Chemistry American Journal of Health-System Pharmacy NHS Health Technology Assessment

Thousands of drugs from more than 1,000 branded and generic firms

Pharmaceutical Classes

Drugs Profiled

Branded and Generic Firms

Global Patents


Frequently Asked Questions

DrugPatentWatch has patent coverage for the following countries and regional organizations:

African Intellectual Property Organization (OAPI) African Regional IP Organization (ARIPO) Algeria Argentina Australia Austria Bahrain (GCC) Belgium Benin (OAPI) Bosnia and Herzegovina Botswana (ARIPO) Brazil Bulgaria Burkina Faso (OAPI) Cameroon (OAPI) Canada Central African Republic (OAPI) Chad (OAPI) Chile China Colombia Comoros (OAPI) Congo-Brazzaville (OAPI) Costa Rica Croatia Cuba Cyprus Czech Republic Czechoslovakia Côte d'Ivoire (OAPI) Denmark Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea (OAPI) Estonia Eurasian Patent Organization European Patent Office Finland France Gabon (OAPI) Georgia, Republic of German Democratic Republic Germany Ghana (ARIPO) Greece Guatemala Guinea (OAPI) Guinea-Bissau (OAPI) Gulf Cooperation Council Honduras Hong Kong Hungary Iceland India Indonesia Ireland Israel Italy Japan Jordan Kenya (ARIPO) Kuwait (GCC) Latvia Lesotho (ARIPO) Liberia (ARIPO) Lithuania Luxembourg Malawi (ARIPO) Malaysia Mali (OAPI) Mauritania (OAPI) Mexico Moldova, Republic of Monaco Montenegro Morocco Mozambique (ARIPO) Namibia (ARIPO) Netherlands New Zealand Nicaragua Niger (OAPI) Norway Oman (GCC) Panama Peru Philippines Poland Portugal Qatar (GCC) Romania Russian Federation Rwanda (ARIPO) San Marino Saudi Arabia (GCC) Senegal (OAPI) Serbia Sierra Leone (ARIPO) Singapore Slovakia Slovenia Somalia (ARIPO) South Africa South Korea Spain Sudan (ARIPO) Swaziland (ARIPO) Sweden Switzerland São Tomé and Príncipe (ARIPO) Taiwan Tajikistan Tanzania (ARIPO) The Gambia (ARIPO) Togo (OAPI) Tunisia Turkey Uganda (ARIPO) Ukraine United Arab Emirates (GCC) United Kingdom United States of America Uruguay Viet Nam Yugoslavia Zambia (ARIPO) Zimbabwe (ARIPO)

Adding an alert is as easy as clicking the 'Add Alert' button on a page of interest.

    Available alerts include:

  • Paragraph IV challenges
  • New drugs and added or expired patents per company
  • Added or expired patents per drug
  • Tentative approvals

The Enterprise Plan enables unlimited users (identified by IP blocks), within your organization. The Single User plans cannot be shared, but multiple accounts can be purchased for a substantial discount.

The simplest way to get a pro forma invoice is to select the most appropriate subscription plan and proceed with your order. There is an option to request an invoice for offline payment.

Alternatively, you may use the contact form to tell us which subscription plan you would like an invoice for.

No problem. Please use the contact form and let us know how we can be of assistance.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Database Highlights

  • Daily patent updates
  • Suppliers and manufacturers
  • Formulation and manufacturing
  • Paragraph IV challenges
  • Impending generic entry
  • International patent families
  • Clinical trial information
  • Expired and active patents
  • Authorized generic drugs
  • Export to Excel or csv

For more information try a trial or see the database preview and plans and pricing

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Related Products from thinkBiotech

Connect with Social Media: